CYTK insider trading
SEC Form 4 transactions reported by Cytokinetics, Incorporated insiders, officers, directors, and 10%+ beneficial owners. Sourced from EDGAR.
Want this data via API instead of reading about it? Get a free API key →
Recent CYTK insider transactions
The 20 most recent non-derivative Form 4 transactions reported by Cytokinetics, Incorporated insiders. Buys are highlighted; the transaction code column matches SEC Form 4 codes (P = open-market purchase, S = sale, A = grant, M = option exercise, F = tax withholding).
| Date | Code | Insider | Role | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | S | Malik Fady Ibraham | EVP Research & Development | 3,500 | $87 | $303K |
| 2026-07-07 | M | Malik Fady Ibraham | EVP Research & Development | 3,500 | $8 | $27K |
| 2026-07-01 | S | Blum Robert I | President & CEO, Director | 7,500 | $85 | $637K |
| 2026-07-01 | M | Callos Andrew | EVP, Chief Commercial Officer | 15,000 | $23 | $349K |
| 2026-07-01 | S | Callos Andrew | EVP, Chief Commercial Officer | 15,000 | $86 | $1.3M |
| 2026-07-01 | M | Lee Sung | EVP, Chief Financial Officer | 1,112 | $49 | $54K |
| 2026-07-01 | S | Lee Sung | EVP, Chief Financial Officer | 1,112 | $88 | $98K |
| 2026-06-29 | M | Lee Sung | EVP, Chief Financial Officer | 188 | $44 | $8K |
| 2026-06-29 | S | Lee Sung | EVP, Chief Financial Officer | 3,134 | $85 | $266K |
| 2026-06-29 | M | Lee Sung | EVP, Chief Financial Officer | 822 | $44 | $36K |
| 2026-06-29 | M | Lee Sung | EVP, Chief Financial Officer | 188 | $44 | $8K |
| 2026-06-29 | M | Lee Sung | EVP, Chief Financial Officer | 1,113 | $49 | $54K |
| 2026-06-29 | M | Lee Sung | EVP, Chief Financial Officer | 823 | $44 | $37K |
| 2026-06-24 | S | Lee Sung | EVP, Chief Financial Officer | 38,730 | $82 | $3.2M |
| 2026-06-24 | M | Lee Sung | EVP, Chief Financial Officer | 188 | $44 | $8K |
| 2026-06-24 | M | Lee Sung | EVP, Chief Financial Officer | 822 | $44 | $36K |
| 2026-06-24 | M | Lee Sung | EVP, Chief Financial Officer | 1,113 | $49 | $54K |
| 2026-06-24 | M | Lee Sung | EVP, Chief Financial Officer | 23,370 | $49 | $1.1M |
| 2026-06-24 | M | Lee Sung | EVP, Chief Financial Officer | 9,307 | $44 | $413K |
| 2026-06-24 | M | Lee Sung | EVP, Chief Financial Officer | 2,817 | $44 | $125K |
What insider trading data covers for CYTK
Cytokinetics, Incorporated (CIK 1061983) reports Section 16 insider transactions on Form 4 within two business days. Each filing carries the transaction date, transaction code (P for open-market purchase, S for sale, M for option exercise, F for tax withholding), shares, price, and post-transaction holdings. Optional footnotes disclose Rule 10b5-1 plan references and indirect ownership relationships.
How to interpret CYTK insider activity
Treat each filing line through three filters: the transaction code, the role of the filer (officer carries more signal than director), and the dollar value relative to the company's market cap. Open-market purchases (P) by C-suite officers carry the strongest bullish signal. Sales (S) referencing a Rule 10b5-1 plan in the footnotes are pre-arranged and should be discounted. See how to read a Form 4 for the full walkthrough.
Get CYTK insider data via API
Pull recent CYTK Form 4 filings, filtered to open-market purchases above $100k:
curl "https://api.edgarkit.com/v1/filings?ticker=CYTK&form_type=4&transaction_code=P&min_value=100000&limit=20" \
-H "Authorization: Bearer YOUR_API_KEY"Subscribe via webhook to receive every new CYTK Form 4 in real time:
curl -X POST "https://api.edgarkit.com/v1/webhooks" \
-H "Authorization: Bearer YOUR_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"url": "https://your-server.com/edgarkit-events",
"filters": {"form_types": ["4"], "tickers": ["CYTK"]}
}'Cluster buying detection for CYTK
The strongest insider signal at the issuer level is cluster buying: three or more distinct insiders placing open-market purchases within a 7-14 day window. For the complete pattern detector, see how to detect insider cluster buying.